September 2026
The global esophageal cancer therapeutics market size was evaluated at USD 3.51 billion in 2026 and is predicted to hit around USD 7.75 billion by 2035, growing at a CAGR of 9.22%.
September 2026
The global esophageal cancer market size is estimated to hit around USD 36.51 billion by 2035 increasing from USD 18.03 billion in 2026, with a CAGR of 8.17%.
August 2025
The global esophageal cancer molecular diagnosis market size is estimated to hit around USD 3.3 billion by 2034 increasing from USD 1.52 billion in 2024, with a CAGR of 8.05%.
September 2026
The global skin cancer diagnostic market size is evaluated at USD 9.42 billion in 2026 and is predicted to hit around USD 14.60 billion by 2035, with a CAGR of 4.99%.
September 2026
The gastric cancer diagnostics market size reached USD 1.42 billion in 2026, with leading gastric cancer diagnostics market companies including GE Healthcare, Siemens Healthineers.
September 2026
The breast cancer core needle biopsy market size stood at USD 1.08 billion in 2026, with major breast cancer core needle biopsy market companies including Intact Medical Corporation, Ethicon Surgical Technologies.
September 2026
The global genomics in cancer care market size was evaluated at USD 28.32 billion in 2026 and is predicted to hit around USD 108.69 billion by 2035, growing at a CAGR of 28.32%.
September 2026
The global lung cancer diagnostics market size is estimated at USD 5.69 billion in 2026 and is predicted to hit around USD 9.45 billion by 2034 with a CAGR of 6.53%.
September 2026
The liver cancer drug market was valued at USD 5.19 billion in 2026, with leading companies including Bayer AG, Bristol Myers Squibb.
September 2026
The global esophageal atresia treatment market size was evaluated at USD 314.58 billion in 2026 and is predicted to hit around USD 578.34 billion by 2035, growing at a CAGR of 7.00%.
September 2026
The lung cancer therapeutics market size totalled USD 38.23 billion in 2026, with major lung cancer therapeutics market players including AstraZeneca, BoehringerIngelheim, Bristol-Myers Squibb Company, Eli Lilly and Company, Hoffmann-La Roche, Merck & Co, Pfizer Inc.
September 2026
The global prostate cancer market size is calculated at USD 13.97 billion in 2026 and is projected to hit around USD 28.83 billion by 2035 with a CAGR of 8.41%.
September 2026
The pancreatic cancer market size was estimated at USD 3.70 billion in 2026 and it is expected to be hit around USD 11.47 billion by 2035 at a CAGR of 13.44%.
September 2026
The global cancer monoclonal antibodies market size reached USD 148.26 billion in 2026 and is predicted to hit around USD 658.07 billion by 2035, with a solid CAGR of 18.06%.
September 2026
The global exosome-based cancer therapy CDMO market is growing as demand rises for scalable manufacturing and delivery solutions in exosome therapeutics.
September 2026
The neoantigen cancer vaccine market was worth USD 551.46 million in 2026, with key neoantigen cancer vaccine market players including Moderna Inc, BioNTech SE.
September 2026
The global small cell lung cancer therapeutics market size is projected to hit around USD 22.86 billion by 2035 from USD 8.14 billion in 2026 with a CAGR of 12.17%.
September 2026
The global cancer therapeutics market size was evaluated at USD 232.14 billion in 2026 and is expected to surpass around USD 501.07 billion by 2035 with a CAGR of 8.95%.
September 2026
The global cancer registry software market size is expected to increase from USD 106.52 million in 2026 to hit around USD 301.40 million by 2035, with a CAGR of 12.28%.
September 2026
The global cancer biomarkers market size was estimated at USD 17.49 billion in 2026 and is projected to hit around USD 47.14 billion by 2035 with a CAGR of 11.71%.
September 2026
The global next-generation cancer diagnostics market size is projected to hit around USD 46.43 billion by 2035 from USD 20.28 billion in 2026, with a CAGR of 9.25%.
September 2026
The cervical cancer diagnostic market size accounted for USD 10.33 billion in 2026 and is expected to hit around USD 16.04 billion by 2035 with a CAGR of 5.03%.
September 2026
The global cancer vaccine market size was calculated at USD 11.32 billion in 2024 and is projected to hit around USD 33.38 billion by 2034 with a soild CAGR of 11.42%.
September 2026
The global stomach cancer treatment market size is estimated to surpass around USD 19.42 billion by 2035 from USD 6.84 billion in 2026, with a solid CAGR of 12.31%.
September 2026
The global head and neck cancer drugs market size surpassed USD 20.09 billion in 2026 and is projected to hit around USD 36.48 billion by 2035 with a CAGR of 6.87%.
September 2026
The cancer biopsy market size is estimated at USD 43.42 billion in 2026 and is expected to hit around USD 196.68 billion by 2035, growing at a CAGR of 18.33%.
September 2026
The global oral cancer rapid test kit market size is estimated to hit around USD 3.94 billion by 2035 increasing from USD 2.50 billion in 2026, with a CAGR of 5.17%.
September 2026
The global lung cancer surgery market size was evaluated at USD 1.64 billion in 2026 and is predicted to hit around USD 2.76 billion by 2035, growing at a CAGR of 5.95%.
September 2026
The global metastatic non-small cell lung cancer market size was evaluated at USD 20.45 billion in 2026 and is predicted to hit around USD 50.30 billion by 2035, growing at a CAGR of 10.52%.
September 2026
The global non-invasive cancer diagnostics market size is projected to hit around USD 350.78 billion by 2035 from USD 185.94 billion in 2026, with a CAGR of 7.32%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com